Skip to main navigation Skip to search Skip to main content

Screening, complications and treatment of gestational diabetes

  • Diabetes and Endocrinology and Research
  • Diabetes and Endocrinology and Fidelma

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

1 Citation (Scopus)

Abstract

Gestational diabetes (GD) is a condition of increasing incidence, largely as a result of a higher prevalence of maternal obesity. Women diagnosed with GD have a greater risk of adverse pregnancy and perinatal outcome and are also more likely to be diagnosed with type 2 diabetes in later life. Recent updated criteria for the diagnosis of gestational diabetes recommend its diagnosis at more modest degrees of hyperglycaemia during pregnancy. However, there is no consensus on how best to screen or diagnose this condition. Recent evidence suggests that treatment with metformin may be a safe alternative or adjunct to insulin. Additionally, active management of lower degrees of maternal hyperglycaemia improves gestational outcome. This article looks at screening guidelines, complications and treatment of GD.

Original languageEnglish
Pages (from-to)337-342
Number of pages6
JournalDiabetes and Primary Care
Volume12
Issue number6
Publication statusPublished - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Gestational diabetes
  • Hyperglycaemia
  • Pregnancy
  • Screening

Fingerprint

Dive into the research topics of 'Screening, complications and treatment of gestational diabetes'. Together they form a unique fingerprint.

Cite this